<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The study was aimed to explore clinical result of <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (CsA) and <z:chebi fb="5" ids="50113">androgens</z:chebi> for treatment of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Four cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-RA were treated with CsA and <z:chebi fb="5" ids="50113">androgens</z:chebi>, while the changes of blood counts, bone marrow and chromosome were observed </plain></SENT>
<SENT sid="2" pm="."><plain>The results showed that substantial hematological response was observed in <z:hpo ids='HP_0000001'>all</z:hpo> four patients, that their <z:hpo ids='HP_0001903'>anemia</z:hpo> improved and <z:hpo ids='HP_0000001'>all</z:hpo> transfusion-dependent patients achieved transfusion independence </plain></SENT>
<SENT sid="3" pm="."><plain>In conclusion, CsA and Adr therapy was well tolerated </plain></SENT>
<SENT sid="4" pm="."><plain>CsA and Adr therapy offer an alternative treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with RA </plain></SENT>
<SENT sid="5" pm="."><plain>The mechanisms of the benifical effect from this therapy remain the subject of an ongoing study </plain></SENT>
</text></document>